HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA
Clinical trials for HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Hormone-Blocking drug shows promise in cancer trial
Disease control Recruiting nowThis study tests MK-5684, a drug that blocks the body from making steroid hormones, in people with breast, ovarian, or endometrial cancer. Researchers want to see if it helps patients live longer without their cancer growing compared to standard treatments. The trial is recruitin…
Matched conditions: HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Weekly chemo boost could help ovarian cancer patients who Don't respond to standard treatment
Disease control Recruiting nowThis phase 3 trial tests whether a denser weekly chemotherapy schedule (carboplatin every 3 weeks plus weekly paclitaxel) can help ovarian cancer patients whose tumors are not responding well to standard treatment. The study enrolls 250 adults with advanced ovarian cancer who hav…
Matched conditions: HIGH-GRADE EPITHELIAL OVARIAN CARCINOMA
Phase: PHASE3 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC